Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04520594 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

OptiMized REsistaNt Starch in Inflammatory Bowel Disease: The MEND Trial

StatusActive, Not Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary completion date changed from estimate of Sep 2025 to Nov 5, 2024
    • Study completion date: Dec 2025 to Dec 31, 2026
    v9
  2. Primary completion date: Oct 30, 2024 to Sep 2025
    • Study completion date: Dec 31, 2024 to Dec 2025
    v8
  3. Primary completion date: Aug 1, 2024 to Oct 30, 2024
    • Study completion date: Aug 1, 2024 to Dec 31, 2024
    v7
  4. Primary completion date: Aug 2023 to Aug 1, 2024
    • Trial status: Recruiting to Active, Not Recruiting
    • Study completion date: Feb 2024 to Aug 1, 2024
    • Site details revised
    v6
  5. 2 versions Re-verified since Jun 5, 2021, no change to tracked fieldsv4-v5
Show 2 earlier versionsHide 2 earlier versions
  1. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Mar 2021 to Mar 3, 2021
    • Site details revised
    v3
  2. Start date: Aug 2020 to Mar 2021
    • Secondary endpoints: 4 to 7
    v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The purpose of the study is to determine if a plant-based resistant starch that is optimized for the individual will target the underlying cause of inflammatory bowel disease and restore a "healthier" gut microbiome in pediatric participants with inflammatory bowel disease.
Trial Details
NCT Number NCT04520594
Lead Sponsor Children's Hospital of Eastern Ontario
Conditions
(from sponsor)		 Crohn Disease, Ulcerative Colitis, Inflammatory Bowel Diseases
Related terms Colitis, Ulcerative, Crohn Disease, Inflammatory Bowel Diseases
Enrollment 100 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov